POU domain class 2-associating factor 1 (BOB1) is a lymphocyte-specific transcriptional coactivator, principally expressed by B-cell lymphocytes, and encoded by the POU2AF1 gene. It partners with octamer-binding transcription factors Oct-1 and Oct-2 to selectively boost transcription of key genes for B-cell maturation, antibody production, and germinal center formation. BOB1 deficiency leads to the absence of germinal centers and severe defects in both B- and T-cell immune responses. Its consistent and specific expression in B-cell-derived malignancies renders it both a diagnostic marker and a potential therapeutic target, including in TCR-engineered cellular therapies for hematological cancers.
Other names
BOB.1OBF-1OCA-BOCABPOU2AF1
02
Mechanism of action
Drugs or therapeutic cells targeting BOB1 act by recognizing intracellular peptides derived from BOB1 presented on MHC molecules, leading to cytotoxic immune responses against B-cell tumors.
Modulation of BOB1 expression or activity could influence B-cell development or survival, affecting tumor and immune cell populations.
03
Biological functions
Regulation of octamer-dependent transcription in lymphocytesControl of gene expression critical for B-cell physiology (immunoglobulin genes, CD20, CRISP-3, CD36)Essential for B-cell differentiation and development, especially germinal center formationPromotes T follicular helper (Tfh) cell differentiationRegulates immune response balance (Th1/Th2)
04
Disease associations
Cancer (especially B-cell lymphomas: follicular center cell lymphoma, diffuse large B-cell lymphoma)Autoimmune tissue inflammationPotential roles in acute myeloid leukemiaOther: generalized defective humoral immunity when absent
05
Safety considerations
Targeting BOB1 may impact normal B-cell development and immune competence, resulting in immunodeficiency or impaired humoral immunityRisk of on-target effects on non-malignant B cells is a therapeutic challenge for targeting transcription factors involved in normal tissue homeostasis
06
Interacting drugs
Specific drug interactions are limited; however, the protein is being explored as a target for TCR-based immunotherapies in B-cell malignancies
07
Biomarkers
BOB1 protein expression is used as a biomarker to distinguish B-cell lymphomas from other cancers, aiding in the diagnosis of diffuse large B-cell lymphoma, follicular lymphoma, and moreIts immunohistochemical detection is standard in hematopathology
Beyond the preview
Go deeper on POU domain class 2-associating factor 1 (BOB1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on POU domain class 2-associating factor 1 (BOB1).